Page 29 - 南京医科大学学报自然科学版
P. 29
第43卷第9期 徐 洋,王 敏,张恒璐,等. 达格列净通过Rffl抑制STAT1/TGF⁃β1信号通路改善糖尿病肾病
2023年9月 肾小管上皮细胞EMT和纤维化[J]. 南京医科大学学报(自然科学版),2023,43(9):1201-1207 ·1207 ·
endothelial cells to aggravate proteinuria in diabetic [21] CHRISTOPH W,LACHIN J M,INZUCCHI S E,et al. Em⁃
nephropathy[J]. Physiol Genomics,2016,48(10):711- pagliflozin and clinical outcomes in patients with type 2
718 diabetes mellitus,established cardiovascular disease,and
[13] LOK S W Y,YIU W H,LI H Y,et al. The PAR⁃1 antago⁃ chronic kidney disease[J]. Circulation,2018,137(2):
nist vorapaxar ameliorates kidney injury and tubulointer⁃ 119-129
stitial fibrosis[J]. Clin Sci,2020,134(21):2873-2891 [22] TANG L,WU Y,TIAN M,et al. Dapagliflozin slows the
[14] GONG E Y,JO H A,PARK S H,et al. VSIG4 induces progression of the renal and liver fibrosis associated with
epithelialmesenchymal transition of renal tubular cells type 2 diabetes[J]. Am J Physiol Endocrinol Metab,
under high⁃glucoseconditions[J]. Life(Basel),2020,10 2017,313(5):E563-E576
(12):354-364 [23] JUDIT H,BALOGH D B,ADAM H,et al. Reduced O ⁃
[15] PEERAPEN P,THONGBOONKERD V. Protective roles GlcNAcylation and tubular hypoxia contribute to the anti⁃
of trigonelline against oxalate⁃induced epithelial⁃to⁃mes⁃ fibrotic effect of SGLT2 inhibitor dapagliflozin in the dia⁃
enchymal transition in renal tubular epithelial cells:An betic kidney[J]. Am J Physiol Ren Physiol,2020,318
in vitro study[J]. Food Chem Toxicol,2020,135:110915 (4):1017-1029
[16] WANG Y N,ZHAO S L,SU Y Y,et al. Astragaloside Ⅳ [24] HUANG F J,ZHAO Y Y,WANG Q Z,et al. Dapagliflozin
attenuates high glucose ⁃ induced EMT by inhibiting the attenuates renal tubulointerstitial fibrosis associated with
TGF⁃ β/Smad pathway in renal proximal tubular epithelial type 1 diabetes by regulating STAT1/TGFβ1 signaling
cells[J]. Biosci Rep,2020,40(6):20190987 [J]. Front Endocrinol(Lausanne),2019,10:441
[17] ZHANG L,WANG H,TIAN L,et al. Expression of USP7 [25] 林远灿,骆海莺,刘慧芳,等. 垂盆草总黄酮通过TGF⁃β
and MARCH7 is correlated with poor prognosis in epithe⁃ 1/Smad2/3 通路干预肝星状细胞上皮间质转化的分子
lial ovarian cancer[J]. Tohoku J Exp Med,2016,239(3): 机制[J]. 中药材,2020,43(1):202-205
165-175 [26] ZHANG H Y,CHEN F Y,FAN X,et al. Quantitative pro⁃
[18] TERMEN S,TAN E J,HELDIN C H,et al. p53 regulates teomic analysis on activated hepatic stellate cells rever⁃
epithelial⁃mesenchymal transition induced by transform⁃ sion reveal STAT1 as a key regulator between liver fibro⁃
ing growth factor beta[J]. Cell Physiol,2013,228(4):801 sis and recovery[J]. Sci Rep,2017,7:44910
[19] YANG W,DICKER D T,CHEN J,et al. CARPs enhance [27] KAOWINN S,KAEWPIBOON C,KOH S S,et al.
p53 turnover by degrading 14⁃3⁃3 sigma and stabilizing STAT1 ⁃ HDAC4 signaling induces epithelial ⁃ mesenchy⁃
MDM2[J]. Cell Cycle,2008,7(5):670-682 mal transition and sphere formation of cancer cells overex⁃
[20] DEKKERS⁃CLAIRE C J,SERGEI P,LAVERMAN G D, pressing the oncogene,CUG2[J]. Oncol Rep,2018,40
et al. Effects of the SGLT⁃2 inhibitor dapagliflozin on glo⁃ (5):2619-2627
merular and tubular injury markers[J]. Diabetes Obes [收稿日期] 2023-02-27
Metab,2018,20(8):1988-1993 (本文编辑:陈汐敏)